Market Overview

FDA's Orange Book Doesn't Include Amarin's Vascepa NCE Status in November Report - Bloomberg

Share:
Related AMRN
Benzinga's Top #PreMarket Losers
These 5 Stocks Have More Than Doubled In 2015

View Orange Book.

Posted-In: News FDA

 

Related Articles (AMRN)

Get Benzinga's Newsletters